Cargando…
CXCR4 Antagonism Attenuates the Development of Diabetic Cardiac Fibrosis
Heart failure (HF) is an increasingly recognized complication of diabetes. Cardiac fibrosis is an important causative mechanism of HF associated with diabetes. Recent data indicate that inflammation may be particularly important in the pathogenesis of cardiovascular fibrosis. We sought to determine...
Autores principales: | Chu, Po-Yin, Walder, Ken, Horlock, Duncan, Williams, David, Nelson, Erin, Byrne, Melissa, Jandeleit-Dahm, Karin, Zimmet, Paul, Kaye, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516278/ https://www.ncbi.nlm.nih.gov/pubmed/26214690 http://dx.doi.org/10.1371/journal.pone.0133616 |
Ejemplares similares
-
CXCR4 Antagonism Reduces Cardiac Fibrosis and Improves Cardiac Performance in Dilated Cardiomyopathy
por: Chu, Po-Yin, et al.
Publicado: (2019) -
N‐acetylcysteine attenuates the development of cardiac fibrosis and remodeling in a mouse model of heart failure
por: Giam, Beverly, et al.
Publicado: (2016) -
N-Acetylcysteine Attenuates the Development of Renal Fibrosis in Transgenic Mice with Dilated Cardiomyopathy
por: Giam, Beverly, et al.
Publicado: (2017) -
Pre‐clinical evidence of a dual NADPH oxidase 1/4 inhibitor (setanaxib) in liver, kidney and lung fibrosis
por: Thannickal, Victor J., et al.
Publicado: (2023) -
Abnormal Mitochondrial L-Arginine Transport Contributes to the Pathogenesis of Heart Failure and Rexoygenation Injury
por: Williams, David, et al.
Publicado: (2014)